News

Latest from Tirecat Health

Milestones, awards and updates on our way to the clinic.

The Tirecat Health team

October 2026

Tirecat Health strengthens its team on the road to the clinic

Clinical, product and regulatory expertise join the founders to prepare first-in-human in 2027.

CSIC joins Tirecat Health as a shareholder

22 September 2026

CSIC joins Tirecat Health as a shareholder

CSIC enters the company by transfer from ICN2: the two institutions behind the RESKIN patents are now both shareholders.

Dr. Verónica Arévalo – Health Innovation Fellowships, “la Caixa” Foundation

September 2026

Verónica Arévalo joins Tirecat Health through the “la Caixa” Health Innovation Fellowships

Tirecat Health is one of the host companies of the first, pilot edition of the “la Caixa” Health Innovation Fellowships.

Tirecat Health wins the Transfiere Deep Tech Start-ups award

March 2025

Tirecat Health wins Transfiere “V Open Deep Tech Start-ups”

Recognised as one of the best deep-tech start-ups in the Spanish ecosystem.

RESKIN membrane with the “la Caixa” Foundation logo

December 2024

RESKIN gets under way: Tirecat Health joins the CaixaImpulse project as linked third party

The “la Caixa” Foundation supports RESKIN with €150,000. As linked third party, Tirecat Health works with ICN2 to turn the results into a product.

August 2024

Tirecat Health is founded: from ICN2–CSIC research to patients

Born in the NANOSFUN group at ICN2, after more than ten years of research on bioinspired catechol chemistry.

In the media

Tirecat in the press

What the media say about Tirecat Health and RESKIN.

Let’s work together

Clinicians, industry partners and investors: we would like to hear from you.